CardioInsight Technologies, a US-based healthcare company previously backed by Japan-based distributor of cardiovascular devices DVX, has appointed Jim Bullock as its chairman.
The company raised $7.6m from undisclosed investors last month.
Bullock was chief executive of Atritech, an electrophysiology company bought by Boston Scientific in 2011, and Endocardial Solutions, a catheter-based cardiac mapping company bought by St. Jude Medical in 2005.
CardioInsight added Steve Arless would step down Chairman and Chief Executive Officer. The company added Charu Ramanathan, co-founder and chief scientific officer, would become interim President.
The company is focussed on getting regulatory clearance for its electrocardiographic mapping technology from US regulator the Food and Drug Administration, it said. The company has already secured CE Mark certification allowing it to sell its product in the European Union.
In January 2011 CardioInsight raised more than $10m from DVX and venture capital firms Draper Triangle Ventures, which led the financing, and Case Technology Ventures, which makes pre-seed stage investments out of Case Western Reserve University. The company raised $750,000 in 2006, when it span off from Case Western Reserve University in a round also backed by Jumpstart, an accelerator.
CardioInsight has put in place commercial installations at St. Mary’s Hospital in London, England, the Kerckhoff Clinic in Bad Nauheim, Germany and the Hopital Cardiologique du Haut-Leveque in Bordeaux, France.